Nuveen Asset Management, LLC Rocket Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 167,716 shares of RCKT stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

167,716

Previous 167,716 -0.0%

Holding current value

$2.37 Million

Previous $3.61 Million 14.21%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$20.66 - $26.72 $158,668 - $205,209	7,680 Added 4.8%	167,716 $3.61 Million
Q1 2024 May 13, 2024	SELL	$26.16 - $30.74 $88,499 - $103,993	-3,383 Reduced 2.07%	160,036 $4.31 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $196,963 - $374,911	11,738 Added 7.74%	163,419 $4.9 Million
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $41,653 - $66,474	-2,764 Reduced 1.79%	151,681 $3.11 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $20,272 - $28,839	1,222 Added 0.8%	154,445 $3.07 Million
Q1 2023 May 15, 2023	SELL	$15.79 - $22.6 $5.53 Million - $7.92 Million	-350,498 Reduced 69.58%	153,223 $2.62 Million
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $4.21 Million - $6.18 Million	271,332 Added 116.76%	503,721 $9.86 Million
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $1.57 Million - $2.34 Million	-127,151 Reduced 35.36%	232,389 $3.71 Million
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $584,988 - $1.22 Million	73,491 Added 25.69%	359,540 $4.95 Million
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $1.77 Million - $3.19 Million	134,610 Added 88.89%	286,049 $4.33 Million
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $390,351 - $653,366	-18,139 Reduced 10.7%	151,439 $3.31 Million
Q3 2021 Nov 12, 2021	SELL	$27.42 - $48.97 $2.86 Million - $5.11 Million	-104,351 Reduced 38.09%	169,578 $5.07 Million
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $2.3 Million - $2.76 Million	58,375 Added 27.08%	273,929 $12.1 Million
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $3.37 Million - $5.12 Million	77,714 Added 56.38%	215,554 $9.56 Million
Q4 2020 Feb 16, 2021	SELL	$23.3 - $59.57 $3.33 Million - $8.53 Million	-143,124 Reduced 50.94%	137,840 $4.42 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $1.73 Million - $2.42 Million	-84,567 Reduced 23.14%	280,964 $6.42 Million
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $889,163 - $1.51 Million	66,754 Added 22.34%	365,531 $7.65 Million
Q1 2020 May 14, 2020	BUY	$9.71 - $25.11 $1.83 Million - $4.74 Million	188,830 Added 171.75%	298,777 $4.17 Million
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $67,848 - $148,505	6,129 Added 5.9%	109,947 $2.5 Million
Q3 2019 Nov 14, 2019	SELL	$10.85 - $14.78 $52,882 - $72,037	-4,874 Reduced 4.48%	103,818 $1.21 Million
Q2 2019 Aug 15, 2019	BUY	$15.0 - $19.81 $1.63 Million - $2.15 Million	108,692 New	108,692 $1.63 Million

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Rocket Pharmaceuticals, Inc. Transaction History